Insulin detemir biosimilar?

Short answer: As of now, there are no FDA-approved biosimilars for insulin detemir (brand name Levemir).

A few related points that might help:
- Biosimilars for other insulins exist. In the US, the available biosimilar insulins include:
- Glargine biosimilars: Basaglar and Semglee (both biosimilars to Lantus)
- Lispro biosimilar: Admelog (biosimilar to Humalog)
- There are no approved detemir biosimilars in major markets (US or EU) to date.
- If you’re considering alternatives due to cost or availability, a clinician might discuss switching to a different basal insulin (for example, glargine or degludec), but dosing and timing can differ and should be managed by a healthcare professional.
- Always talk with your prescriber before any switch, since insulin products are dosed carefully to maintain blood sugar control and avoid hypoglycemia.

If you tell me your country or region (US, EU, etc.) and what you want to know (latest approvals, pricing, switching options), I can pull up the most current details.